An innovative approach uses artificial intelligence and biosensors to pave the way for faster drug development.

Yi Lu and Lauren Ehrlich of the College of Natural Sciences are among the cancer researchers with exciting projects on the horizon.

The discovery could lead to better treatments for acute myeloid leukemia in vulnerable populations.

From a brain decoder to a supermassive black hole to a cancer drug advance, College of Natural Sciences researchers made breakthroughs this year.

Bacteria use iron levels to store memories and pass them on to later generations, scientists have found.

Ruth Buskirk and Michael Marder are among the 2023 inductees to The University of Texas at Austin’s prestigious Academy of Distinguished Teachers.

A team led by Lauren Ehrlich found a link between myeloid cells and the cancer that often strikes children.

Drug candidate developed by Everett Stone and his team is effective in mice with cancers of skin, bladder, blood and colon.

Kyle Miller and his team discovered a potential new target for drug therapies: structures in our DNA called R-loops.

Hong Qiao, a plant researcher, explains the science behind produce ripening, and how anyone can prolong shelf life.